Higher levels of IL-17 and IFN-γ in serum in individuals with relapse remitting MS (RRMS) and a negative correlation between level of ambulation and IL-17 and IFN-γ levels have also been found (Pasquali et al., 2015). This evidence concerns the gene IL17A and relapsing-remitting multiple sclerosis.